Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study - Wikidata - wikimedia - TriplyDB

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study

http://www.wikidata.org/entity/Q34926430

about

The relationship between specific cognitive domains, fear of falling, and falls in people with multiple sclerosis The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis Hyperbaric oxygen can induce neuroplasticity and improve cognitive functions of patients suffering from anoxic brain damage.Ocular motor signatures of cognitive dysfunction in multiple sclerosis.Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions.Information processing speed in multiple sclerosis: Past, present, and future.Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis.Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis.Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.Hyperbaric Oxygen Therapy Can Induce Angiogenesis and Regeneration of Nerve Fibers in Traumatic Brain Injury Patients.Reduced information processing speed as primum movens for cognitive decline in MS.Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests.Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.Hyperbaric oxygen may induce angiogenesis in patients suffering from prolonged post-concussion syndrome due to traumatic brain injury.Investigating Domain-Specific Cognitive Impairment Among Patients With Multiple Sclerosis Using Touchscreen Cognitive Testing in Routine Clinical Care.

P2860

Q34039978-D3F0F6FE-E606-490A-BECD-A8CDC6676A9F Q35280640-5F3E6446-9D1C-4DA5-B7A0-31712508C1DC Q35529255-EE51C816-E8FF-417E-8A51-29B817AB0F89 Q35760156-A32759CB-2E69-4768-A77F-8D0113347312 Q35814993-85C333CA-2F22-4C1C-9D1A-97677E88D334 Q37044137-029E0262-B13F-4B93-8561-52E4B3490AEF Q38586620-8B41C651-FA03-48AF-94E0-F88C457B2F49 Q38625426-1693AAAC-6ED2-41D1-BD2E-3396E4DAEE04 Q38649412-05112F1F-CE8A-491E-9325-5892418A7695 Q38666303-A0DA3721-C08E-432B-A6A4-4C08A7E50728 Q38840386-F844430E-87C8-46F6-BF8D-101DC3239113 Q38873031-B47BAE5C-7FD6-4BA7-BE7D-1EA6C9F1DD79 Q38937798-E420FE6B-AF3F-4283-907F-38033DC1DB5A Q40302141-80F8E4E7-4EC4-4165-B40D-683E6674A2DA Q40542938-B7301082-4EF1-4AF3-891A-DA604B0CD8D4 Q43260567-1A4FF152-AF33-4EF8-A58E-51A82F3717B4 Q46788130-8C6B7FA7-936B-44CF-B42A-E9869229D523 Q47236224-55140165-0D74-454B-AF48-D2BC1488E1F9 Q47691178-67E9257D-795C-44E4-8B3E-BC95227AE4C2 Q48704199-5ABB27C0-FBDB-4657-B67F-5AB609D8D815 Q48748004-66124066-7064-4444-8418-5DC82A1B5E43 Q49349492-8D58BAD1-5255-42B6-9B35-1BC2E21CF06D Q50498367-9236BA8A-E29A-4C22-985F-15DF2C906CCD Q52147745-8970C6DC-2010-47D3-B41B-1546A9E7C7DA Q55172321-90330B46-CA75-4099-9BF9-8D77F5F6AE59

P2860

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study

http://www.wikidata.org/entity/Q34926430

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@ast

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@en

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@nl

type

label

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@ast

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@en

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@nl

prefLabel

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@ast

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@en

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@nl

P1433

Q34926430-63FD03C1-FF57-41E3-B121-848E047F7077

P1476

Q34926430-BCA4AD59-69C2-434A-9C36-48CEAF10782C

P2093

Q34926430-0511E108-5B0B-47A7-BBF1-B6F00A15DEAF

Q34926430-07A0E103-EBD9-4145-9A60-A5D909469D8C

Q34926430-268A13FD-CDC3-4961-89F3-3C0D939E504E

Q34926430-3D6BB42A-4079-441E-ADB9-9403260B2F0A

Q34926430-4CDB0E96-F7D8-48B2-A29A-C52C76AE7006

Q34926430-5506EA81-E16D-4051-BD12-EB11380F2644

Q34926430-640E0287-F8C4-41C5-BC86-72357C443CFE

Q34926430-6EAEBAC4-A2B7-492D-8A33-DE530E66BEF2

Q34926430-8DEDF116-13BB-4EEE-AEB6-DFCF13E0D793

Q34926430-9A60CFC4-460F-465E-A4B3-AEE86B6CFB81

P2860

Q34926430-093B6016-905D-4F42-B96F-B9E1A9DE42CE

Q34926430-122C6594-3819-46A5-A928-225D6E8B5948

Q34926430-1ADDD164-6C43-4AFF-8721-81C588E433D2

Q34926430-1BDD9F18-C523-462D-9CF8-FD1EC39C2BAB

Q34926430-1D163008-5E6C-454D-96E5-03D2D5CDF124

Q34926430-1EAB732A-9A50-4576-AAA9-DE2152F4BE70

Q34926430-21E9228B-66F0-4399-9883-EDA26E78B0EA

Q34926430-234637B7-0E06-4C24-8B3D-C385FF5413ED

Q34926430-30287824-C5B5-4760-A680-1C1974B3F3A6

Q34926430-32C0AEBD-3CD0-4823-9E82-9F636E5ACEC4

P304

Q34926430-F63B9A5A-E7B0-4AE7-B489-5882AB89800B

P31

Q34926430-D9883A06-E944-457C-806E-8CA6034DB7A3

P356

Q34926430-DFC896CF-0879-4A17-8B9F-72F3C31225CB

P407

Q34926430-1CAAAA52-395F-4425-8C12-EF9040ADF4CC

P433

Q34926430-121C1594-89A4-4213-B8EF-8EE047D8B84A

P478

Q34926430-D8BFE897-584B-4DA7-8371-773D7E268582

P50

Q34926430-07C038E7-BD4A-4AC1-9952-7E20A8201493

Q34926430-9E1F81D2-B31C-4565-8EC3-15CC1052FBDB

Q34926430-EA7FC3B8-D663-49DB-B904-41CFE298F225

P577

Q34926430-68F0E45D-9D27-488F-ABFA-E53EC0107733

P5875

Q34926430-7B6D2451-8713-44CB-9AAF-186DB6C48BC4

P698

Q34926430-4E70C98B-9E4F-4B1C-B445-720BEB81BAB9

P921

Q34926430-8A5F65BA-3071-46BF-AB24-8D213449DDB9

P932

Q34926430-D2725920-CA38-4CB9-990E-C4594FB4F5FD

P356

JOURNAL.PONE.0071058

P1433

P1476

Modeling of cognitive impairme ...... rosis: a cross-sectional study

@en

P2093

Anat Achiron

http://www.w3.org/2001/XMLSchema#string

David Magalashvili

http://www.w3.org/2001/XMLSchema#string

Eran Bercovich

http://www.w3.org/2001/XMLSchema#string

Gil Hararai

http://www.w3.org/2001/XMLSchema#string

Mark Dolev

http://www.w3.org/2001/XMLSchema#string

Michael Polliack

http://www.w3.org/2001/XMLSchema#string

Micharel Gurevich

http://www.w3.org/2001/XMLSchema#string

Mor Lavie

http://www.w3.org/2001/XMLSchema#string

Olga Khilkevich

http://www.w3.org/2001/XMLSchema#string

Shay Menascu

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Cognitive impairment in probable multiple sclerosis

Validity of a novel computerized cognitive battery for mild cognitive impairment

Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

Cognitive impairment in multiple sclerosis

Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.

Alemtuzumab versus interferon β-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.

Risk factors for and management of cognitive dysfunction in multiple sclerosis.

P304

e71058

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0071058

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Glen M. Doniger

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255737367

http://www.w3.org/2001/XMLSchema#string

P698

23936485

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3731335

http://www.w3.org/2001/XMLSchema#string